Progress in Antisense Technology
Top Cited Papers
- 1 February 2004
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 55 (1) , 61-95
- https://doi.org/10.1146/annurev.med.55.091902.104408
Abstract
Antisense technology exploits oligonucleotide analogs to bind to target RNAs via Watson-Crick hybridization. Once bound, the antisense agent either disables or induces the degradation of the target...Keywords
This publication has 127 references indexed in Scilit:
- O-108 Randomized phase III trial of chemotherapy and antisense oligonucleotide LY900003 (ISIS 3521) in patients with advanced NSCLCLung Cancer, 2003
- Ancient Pathways Programmed by Small RNAsScience, 2002
- RNAiCell, 2000
- Preclinical Evaluation of the Effects of a Novel Antisense Compound Targeting C-rafKinase in Mice and MonkeysToxicological Sciences, 1998
- Preclinical Profiling of Modified Oligonucleotides: Anticoagulation and Pharmacokinetic PropertiesNucleosides and Nucleotides, 1997
- Inhibition of Interferon-γ-Induced Intercellular Adhesion Molecule-1 Expression on Human Keratinocytes by Phosphorothioate Antisense Oligodeomynucleotides Is the Consequence of Antisense-Specific and Antisense-Non-Specific EffectsJournal of Investigative Dermatology, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Suppression of Neointimal Smooth Muscle Cell Accumulation in Vivo by Antisense cdc2 and cdk2 Oligonucleotides in Rat Carotid ArteryBiochemical and Biophysical Research Communications, 1994
- Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virusLife Sciences, 1994
- Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense OligodeoxynucleotidesScience, 1993